Saori Sakaue, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genome-Wide Association Study | 37 | 2024 | 12690 | 1.790 |
Why?
|
Genetic Predisposition to Disease | 23 | 2024 | 17904 | 1.060 |
Why?
|
Multifactorial Inheritance | 6 | 2022 | 1387 | 1.020 |
Why?
|
HLA Antigens | 4 | 2024 | 1328 | 0.990 |
Why?
|
Japan | 15 | 2024 | 1378 | 0.960 |
Why?
|
Arthritis, Rheumatoid | 6 | 2024 | 3763 | 0.790 |
Why?
|
Genetics, Population | 3 | 2024 | 937 | 0.790 |
Why?
|
Polymorphism, Single Nucleotide | 26 | 2024 | 15936 | 0.750 |
Why?
|
Biological Specimen Banks | 4 | 2024 | 783 | 0.750 |
Why?
|
Disease | 2 | 2024 | 672 | 0.740 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2024 | 790 | 0.740 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2021 | 41 | 0.720 |
Why?
|
Multifactor Dimensionality Reduction | 1 | 2020 | 10 | 0.710 |
Why?
|
Single-Cell Analysis | 5 | 2024 | 2451 | 0.680 |
Why?
|
Alcohol Dehydrogenase | 1 | 2019 | 111 | 0.650 |
Why?
|
Drug Repositioning | 1 | 2019 | 233 | 0.570 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 891 | 0.570 |
Why?
|
Graves Disease | 1 | 2018 | 238 | 0.560 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2023 | 1349 | 0.550 |
Why?
|
Quantitative Trait Loci | 6 | 2024 | 2116 | 0.530 |
Why?
|
Alleles | 10 | 2024 | 6864 | 0.520 |
Why?
|
Genome, Human | 7 | 2024 | 4425 | 0.520 |
Why?
|
Takayasu Arteritis | 1 | 2016 | 105 | 0.480 |
Why?
|
Major Histocompatibility Complex | 4 | 2021 | 870 | 0.460 |
Why?
|
Exophthalmos | 1 | 2015 | 97 | 0.450 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2014 | 42 | 0.450 |
Why?
|
Genetic Markers | 1 | 2020 | 2601 | 0.440 |
Why?
|
Aorta, Abdominal | 1 | 2016 | 625 | 0.440 |
Why?
|
Genetic Association Studies | 3 | 2021 | 2735 | 0.440 |
Why?
|
Autoimmune Diseases | 3 | 2024 | 2244 | 0.430 |
Why?
|
Longevity | 1 | 2020 | 1065 | 0.400 |
Why?
|
Autoantibodies | 1 | 2021 | 2118 | 0.400 |
Why?
|
Gene Regulatory Networks | 3 | 2020 | 1745 | 0.390 |
Why?
|
Genome | 1 | 2019 | 1740 | 0.380 |
Why?
|
Synovial Membrane | 2 | 2024 | 532 | 0.370 |
Why?
|
Body Height | 3 | 2022 | 1570 | 0.370 |
Why?
|
Chromatin | 4 | 2024 | 2961 | 0.320 |
Why?
|
Genetic Loci | 5 | 2021 | 2632 | 0.310 |
Why?
|
Chromosome Mapping | 4 | 2024 | 4615 | 0.310 |
Why?
|
Mortality | 1 | 2019 | 2902 | 0.300 |
Why?
|
Asthma | 2 | 2018 | 6234 | 0.300 |
Why?
|
Phenotype | 12 | 2024 | 16592 | 0.290 |
Why?
|
MicroRNAs | 2 | 2022 | 3816 | 0.270 |
Why?
|
Colitis, Ulcerative | 1 | 2018 | 1922 | 0.270 |
Why?
|
Genomics | 6 | 2024 | 5821 | 0.270 |
Why?
|
Genetic Variation | 6 | 2024 | 6567 | 0.260 |
Why?
|
Gene Frequency | 6 | 2022 | 3606 | 0.250 |
Why?
|
Haplotypes | 4 | 2023 | 2713 | 0.230 |
Why?
|
Linkage Disequilibrium | 7 | 2024 | 1998 | 0.230 |
Why?
|
Antirheumatic Agents | 1 | 2014 | 1373 | 0.230 |
Why?
|
Genetic Pleiotropy | 2 | 2022 | 181 | 0.220 |
Why?
|
Physical Chromosome Mapping | 1 | 2021 | 183 | 0.190 |
Why?
|
Mendelian Randomization Analysis | 3 | 2022 | 1007 | 0.190 |
Why?
|
Selection, Genetic | 3 | 2021 | 868 | 0.190 |
Why?
|
Humans | 50 | 2024 | 761596 | 0.180 |
Why?
|
Pulmonary Surfactants | 1 | 2021 | 162 | 0.180 |
Why?
|
Amino Acids | 2 | 2023 | 1718 | 0.170 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2021 | 367 | 0.170 |
Why?
|
Meta-Analysis as Topic | 2 | 2021 | 1380 | 0.160 |
Why?
|
Genotype | 6 | 2024 | 12990 | 0.160 |
Why?
|
Blood Proteins | 1 | 2024 | 1173 | 0.160 |
Why?
|
ABO Blood-Group System | 1 | 2021 | 380 | 0.160 |
Why?
|
Finland | 1 | 2020 | 607 | 0.160 |
Why?
|
Chromosomes, Human | 1 | 2020 | 441 | 0.150 |
Why?
|
Principal Component Analysis | 1 | 2020 | 945 | 0.140 |
Why?
|
DNA Copy Number Variations | 2 | 2022 | 2020 | 0.130 |
Why?
|
Protein Isoforms | 1 | 2021 | 1699 | 0.130 |
Why?
|
Gene Expression Regulation | 3 | 2024 | 11904 | 0.120 |
Why?
|
Dental Caries | 1 | 2019 | 427 | 0.120 |
Why?
|
Hypertension | 3 | 2020 | 8540 | 0.120 |
Why?
|
DNA, Mitochondrial | 1 | 2020 | 865 | 0.120 |
Why?
|
Periodontitis | 1 | 2019 | 568 | 0.110 |
Why?
|
Organ Specificity | 1 | 2018 | 1968 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.110 |
Why?
|
Female | 21 | 2024 | 392705 | 0.110 |
Why?
|
Case-Control Studies | 3 | 2021 | 22176 | 0.110 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2016 | 585 | 0.110 |
Why?
|
Psoriasis | 2 | 2024 | 950 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1459 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2178 | 0.100 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 935 | 0.100 |
Why?
|
Forecasting | 2 | 2017 | 2928 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2020 | 2571 | 0.090 |
Why?
|
Eye | 1 | 2015 | 712 | 0.090 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4758 | 0.090 |
Why?
|
Male | 17 | 2024 | 360846 | 0.090 |
Why?
|
Rheumatic Diseases | 1 | 2017 | 649 | 0.090 |
Why?
|
Prednisone | 1 | 2015 | 1563 | 0.090 |
Why?
|
Eosinophils | 1 | 2015 | 950 | 0.090 |
Why?
|
Computational Biology | 2 | 2018 | 3517 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2018 | 1886 | 0.080 |
Why?
|
Drug Discovery | 1 | 2017 | 1051 | 0.080 |
Why?
|
Middle Aged | 10 | 2024 | 220921 | 0.080 |
Why?
|
Base Sequence | 1 | 2020 | 12441 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9610 | 0.080 |
Why?
|
Odds Ratio | 1 | 2021 | 9647 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 2020 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7581 | 0.080 |
Why?
|
Adult | 10 | 2024 | 221210 | 0.070 |
Why?
|
Stroke | 2 | 2020 | 9758 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 12149 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2022 | 9420 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3624 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 4028 | 0.070 |
Why?
|
Depressive Disorder, Major | 1 | 2024 | 4762 | 0.070 |
Why?
|
Risk Factors | 4 | 2020 | 74213 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2273 | 0.060 |
Why?
|
Software | 1 | 2019 | 4434 | 0.060 |
Why?
|
Radiography | 1 | 2016 | 6965 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 1809 | 0.060 |
Why?
|
Aged | 7 | 2024 | 169310 | 0.060 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3222 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4544 | 0.060 |
Why?
|
Qc-SNARE Proteins | 1 | 2023 | 20 | 0.050 |
Why?
|
Lymphocyte Subsets | 1 | 2024 | 309 | 0.050 |
Why?
|
Age Factors | 1 | 2020 | 18399 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4062 | 0.050 |
Why?
|
Biopsy | 1 | 2015 | 6766 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2024 | 321 | 0.050 |
Why?
|
Databases, Genetic | 2 | 2020 | 1742 | 0.050 |
Why?
|
T-Box Domain Proteins | 1 | 2024 | 469 | 0.050 |
Why?
|
Lipids | 2 | 2022 | 3341 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4687 | 0.050 |
Why?
|
Plasma Cells | 1 | 2024 | 599 | 0.040 |
Why?
|
Population Groups | 1 | 2021 | 208 | 0.040 |
Why?
|
Chromosomes | 1 | 2023 | 578 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6403 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4580 | 0.040 |
Why?
|
Interleukin-7 | 1 | 2020 | 143 | 0.040 |
Why?
|
Fatty Acid Transport Proteins | 1 | 2019 | 31 | 0.040 |
Why?
|
Genetics | 1 | 2020 | 114 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 322 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8601 | 0.040 |
Why?
|
Sample Size | 1 | 2022 | 841 | 0.040 |
Why?
|
Heredity | 1 | 2019 | 148 | 0.040 |
Why?
|
RNA, Untranslated | 1 | 2022 | 459 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1096 | 0.040 |
Why?
|
Tokyo | 1 | 2018 | 25 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 14033 | 0.040 |
Why?
|
Hominidae | 1 | 2018 | 68 | 0.040 |
Why?
|
Inheritance Patterns | 1 | 2020 | 341 | 0.040 |
Why?
|
Railroads | 1 | 2018 | 63 | 0.040 |
Why?
|
Adenosine Triphosphatases | 1 | 2022 | 836 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1003 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3801 | 0.040 |
Why?
|
Quantitative Trait, Heritable | 1 | 2021 | 543 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12947 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1123 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 266 | 0.030 |
Why?
|
Medical History Taking | 1 | 2020 | 774 | 0.030 |
Why?
|
Mutation | 1 | 2021 | 30053 | 0.030 |
Why?
|
Markov Chains | 1 | 2020 | 966 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2024 | 2021 | 0.030 |
Why?
|
Genetic Research | 1 | 2017 | 171 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15502 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3420 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23447 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2201 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10554 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 17354 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2461 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58984 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4142 | 0.030 |
Why?
|
Pattern Recognition, Automated | 1 | 2020 | 997 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2024 | 5485 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22173 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1899 | 0.030 |
Why?
|
Transcription Factors | 2 | 2024 | 12130 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3332 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2022 | 2639 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2024 | 3066 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 2898 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4369 | 0.020 |
Why?
|
Employment | 1 | 2018 | 1118 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4281 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2020 | 2050 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7593 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2020 | 2400 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2024 | 12794 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 59260 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3442 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3725 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36426 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3639 | 0.020 |
Why?
|
Body Mass Index | 1 | 2024 | 12953 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 88326 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15601 | 0.010 |
Why?
|
HIV-1 | 1 | 2021 | 6863 | 0.010 |
Why?
|
Depression | 1 | 2024 | 8126 | 0.010 |
Why?
|
Aging | 1 | 2022 | 8710 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13367 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23996 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26202 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41495 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26129 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 39969 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36193 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42232 | 0.010 |
Why?
|
United States | 1 | 2021 | 72340 | 0.010 |
Why?
|
Child | 1 | 2018 | 80158 | 0.010 |
Why?
|
Animals | 1 | 2018 | 168475 | 0.000 |
Why?
|